当前位置:首页 - 行情中心 - 鹿得医疗(920278) - 财务分析 - 现金流量表

鹿得医疗

(920278)

  

流通市值:7.29亿  总市值:17.19亿
流通股本:7404.80万   总股本:1.75亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金332,050,144.44257,888,364.72132,891,352.36306,969,792.52
  收到的税费返还25,965,083.7919,454,766.6412,570,974.6623,356,324.01
  收到其他与经营活动有关的现金4,518,541.992,647,792.321,040,521.143,783,520.12
  经营活动现金流入小计362,533,770.22279,990,923.68146,502,848.16334,109,636.65
  购买商品、接受劳务支付的现金139,518,490.493,267,454.0449,889,096.17221,727,585.32
  支付给职工以及为职工支付的现金55,855,882.3538,313,224.320,582,513.875,361,712.24
  支付的各项税费7,467,994.696,188,640.13,134,029.458,689,449.83
  支付其他与经营活动有关的现金27,433,241.6813,153,970.418,805,324.1815,298,638.36
  经营活动现金流出小计230,275,609.12150,923,288.8582,410,963.6321,077,385.75
  经营活动产生的现金流量净额132,258,161.1129,067,634.8364,091,884.5613,032,250.9
二、投资活动产生的现金流量:
  收回投资收到的现金500,301,792.65263,972,755.6145,222,591.94228,647,782.11
  取得投资收益收到的现金3,459,815.91435,005.03158,441.97537,899.12
  处置固定资产、无形资产和其他长期资产收回的现金净额---62,792
  收到的其他与投资活动有关的现金--6,610,143.9-
  投资活动现金流入小计503,761,608.56264,407,760.6451,991,177.81229,248,473.23
  购建固定资产、无形资产和其他长期资产支付的现金39,316,308.3431,766,477.6113,727,041.8247,281,972.92
  投资支付的现金580,322,161.07378,033,765.9743,141,538.25207,078,995.45
  支付其他与投资活动有关的现金---14,089,173.8
  投资活动现金流出小计619,638,469.41409,800,243.5856,868,580.07268,450,142.17
  投资活动产生的现金流量净额-115,876,860.85-145,392,482.94-4,877,402.26-39,201,668.94
三、筹资活动产生的现金流量:
  吸收投资收到的现金---490,000
  其中:子公司吸收少数股东投资收到的现金---490,000
  取得借款收到的现金54,900,00054,900,00045,000,00029,800,000
  收到其他与筹资活动有关的现金14,089,173.814,089,173.8--
  筹资活动现金流入小计68,989,173.868,989,173.845,000,00030,290,000
  偿还债务支付的现金30,790,00020,800,00010,900,0009,050,000
  分配股利、利润或偿付利息支付的现金35,612,877.5518,108,161.21403,736.4517,758,676.24
  支付其他与筹资活动有关的现金9,836,996.45227,500-900,000
  筹资活动现金流出小计76,239,87439,135,661.2111,303,736.4527,708,676.24
  筹资活动产生的现金流量净额-7,250,700.229,853,512.5933,696,263.552,581,323.76
四、汇率变动对现金及现金等价物的影响730,153.54-562,928.18341,071.5757,709.56
五、现金及现金等价物净增加额9,860,753.5912,965,736.393,251,817.42-23,530,384.72
  加:期初现金及现金等价物余额128,882,122.09128,882,122.09128,882,122.09152,412,506.81
  期末现金及现金等价物余额138,742,875.68141,847,858.39222,133,939.51128,882,122.09
补充资料:
  净利润-9,817,579.99-27,490,186.03
  资产减值准备--172,343.83-348,365.89
  固定资产和投资性房地产折旧-3,314,452.32-7,072,746.65
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-3,314,452.32-7,072,746.65
  无形资产摊销-521,065.93-468,036.29
  长期待摊费用摊销-145,731.5-405,867.04
  处置固定资产、无形资产和其他长期资产的损失----8,418.08
  公允价值变动损失--603,334.93--110,451.54
  财务费用-1,106,815.78-331,606.62
  投资损失-99,393.91--1,604,777.73
  递延所得税-168,553.4--568,755.07
  其中:递延所得税资产减少-168,553.4--568,755.07
  存货的减少--1,375,423.72-3,521,580.75
  经营性应收项目的减少-68,309,062.65--31,582,405.85
  经营性应付项目的增加-49,590,248.19-3,782,658.48
  现金的期末余额-141,847,858.39-128,882,122.09
  减:现金的期初余额-128,882,122.09-152,412,506.81
  现金及现金等价物的净增加额-12,965,736.3--23,530,384.72
公告日期2025-10-292025-08-262025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑